At the same time, SFRP5 treatment could down regulate the levels of caspase-3 and Bax and up regulate Bcl-2, indicating that SFRP5 could alleviate cardiomyocyte apoptosis in T2DM + MI mice. Here, SFRP5 is linked to type 2 diabetes mellitus.